GPT Healthcare Ltd Falls 3.69%: 4 Key Factors Behind the Steep Decline

3 hours ago

Share Via

GPT Healthcare Ltd’s shares declined by 3.69% over the week ending 27 March 2026, closing at Rs.116.10 from Rs.120.55 the previous Friday. This underperformance contrasted with the Sensex’s smaller 1.46% fall, reflecting company-specific challenges amid a broadly weak market. The stock hit fresh 52-week and all-time lows twice during the week, underscoring persistent bearish momentum driven by deteriorating financials, rising interest costs, and reduced institutional participation.

Key Events This Week

23 Mar: Stock hits 52-week and all-time low at Rs.117.9

24 Mar: Modest recovery with 0.76% gain amid Sensex rally

25 Mar: Further gains of 1.84% on increased volume

27 Mar: Sharp fall to new 52-week and all-time low of Rs.117.6, closing at Rs.116.10 (-4.68%)

Week Open

Rs.120.55

Week Close

Rs.116.10

-3.69%

Week High

Rs.121.80

Sensex Change

-1.46%

23 March: Stock Hits 52-Week and All-Time Low Amid Market Weakness

On 23 March 2026, GPT Healthcare Ltd’s stock reached a fresh 52-week and all-time low of Rs.117.9 intraday, closing at Rs.118.70, down 1.53%. This decline occurred amid a sharp Sensex fall of 3.13%, reflecting a broadly negative market environment. Despite the sector’s 3.2% drop, GPT Healthcare marginally outperformed its peers but remained under pressure due to company-specific concerns.

Financially, the company has reported negative results for three consecutive quarters, with operating profit declining at an annualised rate of 10.80% over five years. Interest expenses surged by 66.79% to Rs.4.42 crores in the latest six months, squeezing profitability and reducing the operating profit to interest coverage ratio to 9.16 times. Institutional investors reduced their stake by 0.72% to 8.94%, signalling cautious sentiment.

24-25 March: Short-Lived Recovery on Market Rally

Following the steep drop, GPT Healthcare’s shares rebounded modestly on 24 and 25 March, gaining 0.76% and 1.84% respectively. The stock closed at Rs.119.60 and Rs.121.80 on these days, supported by a Sensex rally of nearly 2% each day. Volume on 25 March increased to 6,841 shares, indicating some renewed trading interest.

Despite this short-term bounce, the stock remained below all key moving averages, maintaining a bearish technical stance. The company’s valuation metrics, including a price-to-earnings ratio of 24 times and price-to-book of 3.91 times, suggest a discount relative to historical peers but have not translated into sustained price strength.

27 March: Sharp Decline to New Lows Amid Renewed Selling Pressure

The week ended with a sharp reversal on 27 March, as GPT Healthcare’s stock fell 4.68% intraday to a new 52-week and all-time low of Rs.117.6, closing at Rs.116.10. This decline outpaced the Sensex’s 2.11% fall, signalling renewed bearish momentum. The stock underperformed its sector by 0.32% on the day.

Technical indicators remained firmly bearish, with the stock trading below all major moving averages and key momentum indicators such as MACD and KST signalling continued downward pressure. The company’s operating profit to interest coverage ratio remained low at 9.16 times, while return on capital employed (ROCE) stood at 18.76%, the lowest in recent periods.

Institutional investors further reduced their holdings, reflecting ongoing concerns about the company’s financial health and growth prospects. Despite a reasonable dividend yield of 2.06% and strong management efficiency metrics, the stock’s valuation discount has not prevented sustained price weakness.

Daily Price Performance vs Sensex

Date	Stock Price	Day Change	Sensex	Day Change
2026-03-23	Rs.118.70	-1.53%	32,377.87	-3.13%
2026-03-24	Rs.119.60	+0.76%	33,009.57	+1.95%
2026-03-25	Rs.121.80	+1.84%	33,645.89	+1.93%
2026-03-27	Rs.116.10	-4.68%	32,935.19	-2.11%

Key Takeaways

Persistent Downtrend: GPT Healthcare Ltd’s stock continued its downward trajectory, hitting fresh 52-week and all-time lows twice during the week, reflecting sustained bearish sentiment.

Financial Pressures: The company’s operating profit has declined at an annualised rate of 10.80% over five years, with rising interest expenses (+66.79%) squeezing margins and reducing interest coverage to 9.16 times.

Reduced Institutional Confidence: Institutional investors trimmed their holdings by 0.72% to 8.94%, signalling cautious outlook amid deteriorating fundamentals.

Valuation Discount but Weak Price Action: Despite trading at a valuation discount relative to peers and maintaining a dividend yield of around 2%, the stock’s price has failed to stabilise, weighed down by weak earnings and bearish technical indicators.

Conclusion

GPT Healthcare Ltd’s share price performance over the week ending 27 March 2026 highlights a challenging period marked by financial underperformance, rising costs, and diminished investor confidence. While the broader market showed mixed movements, the stock’s sharper decline and fresh lows underscore company-specific headwinds. The combination of negative earnings trends, increased interest burden, and reduced institutional participation has contributed to the sustained downtrend. Although valuation metrics suggest some discount, the prevailing technical and fundamental signals indicate continued caution for investors monitoring this micro-cap healthcare stock.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE